Clinical Supply Drugs Gene Therapy Immune Response 
pharmaphorum
NOVEMBER 2, 2022
The promise in the self-assembling RNA technology lies in its potential to achieve a strong immune response using a lower dose of antigen than the current generation of mRNA shots, although it is generally a larger molecule and may be more challenging to deliver.
Drug Discovery World
NOVEMBER 3, 2022
Paul Viggers , Chief Commercial Officer at TrakCel, explains how it fits into the drug discovery and development sector. . Ten years ago, cell and gene therapy (CGT) was really finding its feet as success stories such as that of Emily Whitehead began to hit the news. The catalysts . References .
Expert insights. Personalized for you.
52 
Let's personalize your content